Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 13,799 | 13,294 | 11,489 | 9,889 | 9,379 |
| Gross Profit | 13,799 | 13,294 | 11,489 | 9,889 | 9,379 |
| Operating Expenses | 59,838 | 62,408 | 50,254 | 46,699 | 45,507 |
| Operating Income | -46,039 | -49,114 | -38,765 | -36,810 | -36,128 |
| Interest Expense | 2,751 | 2,748 | 2,744 | 2,746 | 2,738 |
| Other Income | 1,464 | 3,641 | 3,236 | 2,918 | 3,427 |
| Pre-tax Income | -47,326 | -48,221 | -38,273 | -36,638 | -35,439 |
| Income Tax | N/A | 0 | 0 | N/A | -2,410 |
| Net Income Continuous | -47,238 | -48,221 | -38,273 | -36,638 | -33,029 |
| Net Income | $-47,238 | $-48,221 | $-38,273 | $-36,638 | $-33,029 |
| EPS Basic Total Ops | -0.21 | -0.21 | -0.17 | -0.16 | -0.14 |
| EPS Basic Continuous Ops | -0.20 | -0.21 | -0.17 | -0.16 | -0.15 |
| EPS Diluted Total Ops | -0.21 | -0.21 | -0.17 | -0.16 | -0.14 |
| EPS Diluted Continuous Ops | -0.20 | -0.21 | -0.17 | -0.16 | -0.13 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.21 | -0.17 | -0.16 | -0.15 |
| EBITDA(a) | $-46,643 | $-50,231 | $-40,251 | $-38,894 | $-38,179 |